Join SIO for the second annual NEXT Summit: Novel Explorations in Combination Therapies, taking place 28–29 May 2026 at the Gleacher Center in Chicago.
Experience a one-of-a-kind educational program that delivers cutting-edge, clinically integrated insights, spotlighting the latest advances in combination therapies and an expanded range of organ-specific content. Designed in collaboration with SITC and AASLD, the NEXT Summit offers a dynamic, multidisciplinary environment where attendees can explore breakthrough therapeutic innovations and emerging immunotherapy strategies.
The 2026 NEXT Summit program broadens its focus beyond HCC and liver cancers to include additional disease states, integrating novel therapeutic applications and next-generation combination approaches that reflect the rapidly evolving landscape of patient care and drive forward-thinking treatment strategies.
Learning Objectives
- Key reviews of groundbreaking clinical trials from 2025–2026 shaping the future of patient care
- Innovations in combination therapies and strategic next steps in IO + systemic regimens
- Unprecedented collaboration between AASLD and SITC, bridging interventional oncology with hepatology and immuno-oncology
- A unique, collaborative format designed to spark innovation, accelerate partnerships, and drive actionable change
- Take the opportunity to connect with decision-makers and trailblazers who are defining the next era of therapy
The Future of Interventional Oncology Starts This Summer.
Are you ready for what’s NEXT?
The Society of Interventional Oncology’s NEXT Summit: Novel Explorations in Combination Therapies is provided in collaboration with the Society for Immunotherapy of Cancer and the American Association for the Study of Liver Diseases.